Mumbai, Nov. 5 -- Marksans Pharma announced that its wholly owned subsidiary Relonchem in UK has received Marketing Authorization for its product Exemestane 25mg film-coated tablets from UK MHRA.

Published by HT Digital Content Services with permission from Capital Market....